These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35793045)

  • 1. Prolactin immunoassay: does the high-dose hook effect still exist?
    Raverot V; Perrin P; Chanson P; Jouanneau E; Brue T; Raverot G
    Pituitary; 2022 Aug; 25(4):653-657. PubMed ID: 35793045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pituitary adenomas secreting large amounts of prolactin may give false low values in immunoradiometric assays. The hook effect.
    Petakov MS; Damjanović SS; Nikolić-Durović MM; Dragojlović ZL; Obradović S; Gligorović MS; Simić MZ; Popović VP
    J Endocrinol Invest; 1998 Mar; 21(3):184-8. PubMed ID: 9591215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High prolactin levels may be missed by immunoradiometric assay in patients with macroprolactinomas.
    St-Jean E; Blain F; Comtois R
    Clin Endocrinol (Oxf); 1996 Mar; 44(3):305-9. PubMed ID: 8729527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Giant pituitary prolactinoma with falsely low serum prolactin: the pitfall of the "high-dose hook effect": case report.
    Barkan AL; Chandler WF
    Neurosurgery; 1998 Apr; 42(4):913-5; discussion 915-6. PubMed ID: 9574657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Hook Effect: A Case Study of a Giant Invasive Prolactinoma With Falsely Low Serum Prolactin.
    Gonçalves RF; Vaz MAS; Rollin G; Rassier Isolan G
    Cureus; 2023 Sep; 15(9):e46194. PubMed ID: 37905282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 'hook effect' on serum prolactin estimation in a patient with macroprolactinoma.
    Unnikrishnan AG; Rajaratnam S; Seshadri MS; Kanagasapabathy AS; Stephen DC
    Neurol India; 2001 Mar; 49(1):78-80. PubMed ID: 11303248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Hook effect" in prolactinomas: case report and review of literature.
    Frieze TW; Mong DP; Koops MK
    Endocr Pract; 2002; 8(4):296-303. PubMed ID: 12173917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hook effect in prolactin immunoassays.
    Al Sifri SN; Raef H
    Saudi Med J; 2004 May; 25(5):656-9. PubMed ID: 15138537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Misdiagnosis due to the hook effect in prolactin assay.
    Yener S; Comlekci A; Arda N; Men S; Yesil S
    Med Princ Pract; 2008; 17(5):429-31. PubMed ID: 18685288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Falsely low serum prolactin in two cases of invasive macroprolactinoma.
    Schöfl C; Schöfl-Siegert B; Karstens JH; Bremer M; Lenarz T; Cuarezma JS; Samii M; von zur Mühlen A; Brabant G
    Pituitary; 2002; 5(4):261-5. PubMed ID: 14558675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hook effect and linear range in prolactin assays: distinct confounding entities.
    do Carmo Dias Gontijo M; de Souza Vasconcellos L; Ribeiro-Oliveira A
    Pituitary; 2016 Aug; 19(4):458-9. PubMed ID: 25577219
    [No Abstract]   [Full Text] [Related]  

  • 12. Calmodulin content in human prolactin-secreting pituitary adenoma: an inverse relationship to serum prolactin levels.
    Bridges AJ; Ho AK
    Neurosci Lett; 1988 Jul; 90(1-2):224-8. PubMed ID: 3412646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and drug therapy of prolactinoma.
    Ciccarelli E; Camanni F
    Drugs; 1996 Jun; 51(6):954-65. PubMed ID: 8736617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Giant invasive pituitary prolactinoma with falsely low serum prolactin: the significance of 'hook effect'.
    Fleseriu M; Lee M; Pineyro MM; Skugor M; Reddy SK; Siraj ES; Hamrahian AH
    J Neurooncol; 2006 Aug; 79(1):41-3. PubMed ID: 16598425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential hook effect in prolactin assay in patients with giant prolactinoma.
    Delgrange E; de Hertogh R; Vankrieken L; Maiter D
    Clin Endocrinol (Oxf); 1996 Oct; 45(4):506-7. PubMed ID: 8959094
    [No Abstract]   [Full Text] [Related]  

  • 16. Hormone levels and tumour size response to quinagolide and cabergoline in patients with prolactin-secreting and clinically non-functioning pituitary adenomas: predictive value of pituitary scintigraphy with 123I-methoxybenzamide.
    Colao A; Ferone D; Lastoria S; Cerbone G; Di Sarno A; Di Somma C; Lucci R; Lombardi G
    Clin Endocrinol (Oxf); 2000 Apr; 52(4):437-45. PubMed ID: 10762286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Don't miss prolactinoma! On the importance of measuring prolactin and how it is done].
    Lindstedt G; Lundberg PA; Jakobsson KE; Tägnfors U; Janson PO
    Lakartidningen; 2000 Jan; 97(4):333-6. PubMed ID: 10684228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pituitary prolactin-secreting tumor formation: recent developments.
    Xu RK; Wu XM; Di AK; Xu JN; Pang CS; Pang SF
    Biol Signals Recept; 2000; 9(1):1-20. PubMed ID: 10686432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do the limits of serum prolactin in disconnection hyperprolactinaemia need re-definition? A study of 226 patients with histologically verified non-functioning pituitary macroadenoma.
    Karavitaki N; Thanabalasingham G; Shore HC; Trifanescu R; Ansorge O; Meston N; Turner HE; Wass JA
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):524-9. PubMed ID: 16984247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 25-hydroxyvitamin D Correlation with Prolactin Levels and Adenoma Size in Female Patients with Newly Diagnosed Prolactin Secreting Adenoma.
    Aboelnaga MM; Abdullah N; El Shaer M
    Endocr Metab Immune Disord Drug Targets; 2017; 17(3):219-225. PubMed ID: 28595559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.